Minimal residual disease in cerebrospinal fluid at diagnosis: A more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 53, Issue 1, 2012, Pages 89-95

  Biojone, Estefnia ^a   De Paula Queiróz, Rosane ^a   Valera, Elvis Terci ^a   Odashima, Newton Satoro ^a   Takayanagui, Osvaldo Massaiti ^a   Viana, Marcos Borato ^b   Tone, Luiz Gonzaga ^a   Scrideli, Carlos Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cerebrospinal fluid; Childhood acute lymphoblastic leukemia; Gene rearrangements; Immunoglobulin; Minimal residual disease; T cell receptor

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; EVENT FREE SURVIVAL; HETERODUPLEX ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INFANT; NEOPLASM, RESIDUAL; OUTCOME ASSESSMENT (HEALTH CARE); POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ANTIGEN, T-CELL; REMISSION INDUCTION; TIME FACTORS;

EID: 84855465372     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.606939     Document Type: Article

References (24)

1. Mastrangelo R, Poplack D, Bleyer A, et al. Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukaemia in children: biologic basis for staging, stratification, and treatment. Med Pediatr Oncol 1986;14:191-194. (Pubitemid 16054588)
2. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by ALL-BFM study from 1981 to 1995. Leukemia 2000;14:2205-2222. (Pubitemid 32042262)
3. Silverman LB, Declerck L, Gelber RD, et al. Results of Dana- Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 2000;14:2247-2256. (Pubitemid 32042265)
4. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children ' s Research Hospital. Leukemia 2000;14: 2286-2294. (Pubitemid 32042269)
5. Nachman J, Cherlow J, Sather HN, et al. Eff ect of initial central nervous system (CNS) status on event-free survival (EFS) in children and adolescents with acute lymphoblastic leukemia (ALL). Med Pediatr Oncol 2002;39:277 [Abstract].
6. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol 2008;9:257-268. (Pubitemid 351722945)
7. Evans AE, Gilbert ES, Zandstra R. The increasing incidence of central nervous system leukemia in children. Cancer 1970;26:404-409.
8. O dom LF, Wilson H, Cullen J, et al. Significance of blasts in lowcell- count cerebrospinal fluid specimens from children with acute lymphoblastic leukemia. Cancer 1990;66:1748-1754. (Pubitemid 20381211)
9. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children ' s Cancer Group. Blood 2003;101:3809-3817. (Pubitemid 36857851)
10. Pui CH. Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia. J Clin Oncol 2003;21:179-181.
11. Mahmoud HH, Rivera GK, Hancock ML, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med 1993;329: 314-319. (Pubitemid 23210683)
12. Gilchrist GS, Tubergen DG, Sather HN, et al. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Children Cancer Group report. J Clin Oncol 1994;12:2594-2600. (Pubitemid 24379644)
13. Lauer S, Shuster J, Kirschner P, et al. Prognostic significance of cerebrospinal fluid (CSF) lymphoblasts (LB) at diagnosis (dx) in children with acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 1994;3:317 [Abstract].
14. Tubergen DG, Cullen JW, Boyett JM, et al. Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Children ' s Cancer Group study. J Clin Oncol 1994;12:273-278. (Pubitemid 24056400)
15. Bürger B, Zimmermann M, Mann G, et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003;21:184-188. (Pubitemid 46606145)
16. Scrideli CA, Queiroz RP, Takayanagui OM, et al. Moleculardiagnosis of leukemic cerebrospinal fluid cells in children with newly diagnosed acute lymphoblastic leukemia. Haematologica 2004;89:1013-1015. (Pubitemid 39049914)
17. da Silva Silveira V, Canalle R, Scrideli CA, et al. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 2009;33:898-901.
18. S crideli CA, Assumpçã o JG, Ganazza MA, et al. A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups. Haematologica 2009;94:781-789.
19. B randalise SR, Pinheiro VR, Aguiar SS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-protocol ALL-99. J Clin Oncol 2010;28:1911-1918. Scrideli C
20. Scrideli CA, Queiroz RP, Takayanagui OM, et al. Polymerase chain reaction on cerebrospinal fluid cells in suspected leptomeningeal involvement in childhood acute lymphoblastic leukemia: comparison to cytomorphological analysis. Diagn Mol Pathol 2003;12:124-127. (Pubitemid 37040598)
21. P ui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178. (Pubitemid 43076714)
22. te Loo DM, Kamps WA, van der Does-van den Berg A, et al. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. J Clin Oncol 2006;15:2332-2336. (Pubitemid 46630665)
23. G ajjar A, Harrison PL, Sandlund JT, et al. Traumatic lumbar puncture at diagnosis adversely aff ects outcome in childhood acute lymphoblastic leukemia. Blood 2000;96:3381-3384.
24. P ui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children ' s Research Hospital. Blood 2004;104:2690-2696. (Pubitemid 39434949)